Archives Page

Research Article 

Efficacy and Safety of Sunitinib in Elderly Patients with Advanced Renal Cell Carcinoma at a University Hospital in Japan: Before Immuno-Oncology Therapy Era

Tatsuya Takayama, Akira Fujisaki, Satoshi Ando, Shinsuke Kurokawa and Tatsuo Morita


Japan is a front-line country in the coming super-aging society. As with all cancers in the elderly, the frequency of renal cell carcinoma (RCC) is also increasing in Japan. While clinical encounters with elderly patients with advanced RCC increase, these patients are only infrequently entered into clinical trials [3], and efficacy and safety data in this age range are scarce.

 PDF  |   Full Text